Richard Williams

Richard Williams

Chief Tech/Sci/R&D Officer at KINNATE BIOPHARMA INC.
57 year
Health Technology
Consumer Services
Technology Services

Profile

Richard Williams is currently the Chief Medical Officer at Kinnate Biopharma, Inc. He previously worked as a Clinical Research Medical Director at Amgen, Inc. from 2010 to 2012, as a Senior Medical Director at Puma Biotechnology, Inc. from 2012 to 2015, as the Head-Early Development Oncology Group at Amgen, Inc. from 2016 to 2017, as the Group Director-Medical at GRAIL LLC in 2017, and as the Chief Medical Officer & Head-Oncology Programs at Wuxi NextCode Genomics USA, Inc. from 2018 to 2020.
Dr. Williams holds a doctorate degree from The University of Queensland.

Richard Williams active positions

CompaniesPositionStart
KINNATE BIOPHARMA INC. Chief Tech/Sci/R&D Officer 01/06/2020

Former positions of Richard Williams

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 01/06/2020
GRAIL, INC. Chief Tech/Sci/R&D Officer 01/02/2018
AMGEN INC. Corporate Officer/Principal 01/01/2017
PUMA BIOTECHNOLOGY, INC. Chief Tech/Sci/R&D Officer 01/09/2015
AMGEN INC. Corporate Officer/Principal 01/11/2012
See the detail of Richard Williams's experience

Training of Richard Williams

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

60

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Consumer Services

Health Technology

Health Technology

Technology Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Richard Williams